paclitaxel poliglumex

DRUG14 trials

Sponsors

Memorial Sloan Kettering Cancer Center, Gynecologic Oncology Group, CTI BioPharma, GOG Foundation, Alliance for Clinical Trials in Oncology

Conditions

Advanced Colorectal CancerBreast CancerCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellFallopian Tube CancerFallopian Tube CarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma

Phase 1

Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer

CompletedNCT00060359

Gynecologic Oncology GroupFallopian Tube Carcinoma, Malignant Ovarian Mixed Epithelial Tumor, Ovarian Brenner Tumor +8

Start: 2003-04-30Updated: 2015-05-08

CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer

CompletedNCT00017017

Memorial Sloan Kettering Cancer CenterFallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

Start: 2001-02-28End: 2009-12-31Updated: 2013-05-30

A Pilot Study of PPX in Women With Metastatic Colorectal Cancer

CompletedNCT00598247

University of Southern CaliforniaAdvanced Colorectal Cancer

Start: 2008-01-31End: 2011-07-31Updated: 2014-02-06

A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer

CompletedNCT00660218

State University of New York - Upstate Medical UniversityCarcinoma, Squamous Cell

Start: 2008-03-31End: 2017-04-30Updated: 2021-11-08

Phase 2

CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

CompletedNCT00045682

Gynecologic Oncology GroupPrimary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma

Start: 2002-09-30Updated: 2017-07-13

Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer

CompletedNCT00265733

Alliance for Clinical Trials in OncologyBreast Cancer

Start: 2006-02-28End: 2013-05-31Updated: 2016-12-06

A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer

TerminatedNCT00352690

Washington University School of MedicineCarcinoma, Non-Small-Cell Lung

Start: 2006-04-30End: 2008-06-30Updated: 2016-12-12

Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer

TerminatedNCT00459810

OHSU Knight Cancer InstituteProstate Cancer

Start: 2007-02-28End: 2009-07-31Updated: 2017-04-28

Phase 3

Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

TerminatedNCT00054197

CTI BioPharmaLung Cancer

Start: 2003-01-31End: 2004-10-31Updated: 2020-10-05

Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer

TerminatedNCT00054184

CTI BioPharmaLung Cancer

Start: 2003-01-31End: 2004-10-31Target: 350Updated: 2020-10-05

Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

TerminatedNCT00054210

CTI BioPharmaLung Cancer

Start: 2003-01-31End: 2004-10-31Updated: 2020-10-05

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer

GOG FoundationFallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma +24

Start: 2005-03-21End: 2022-02-22Updated: 2021-09-30

A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.

TerminatedNCT00269828

CTI BioPharmaNSCLC

Start: 2005-12-31End: 2006-12-31Target: 600Updated: 2020-11-24

Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

TerminatedNCT00551733

CTI BioPharmaLung Cancer

Start: 2007-08-31End: 2007-12-25Target: 450Updated: 2020-10-05

Related Papers

Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer.

2022-03-028 citations